Diagnos Laboratorium Utama Tbk. vs Super Bank Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Super Bank Indonesia Tbk. trades at Rp585 (market cap 19.46T, 10.03M 24h volume). The key difference: Super Bank Indonesia Tbk. is far larger — about 62.6× Diagnos Laboratorium Utama Tbk.'s market cap, and Super Bank Indonesia Tbk. is more actively traded (10.03M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | SUPA | |
|---|---|---|
Market Cap | 310.75B | 19.46T |
Volume | 963.6K | 10.03M |
Lot | 9.64K | 100.32K |
Turnover | 217.67M | 5.86B |
Average Price | 225.89 | 584.5 |
Value | 217.67M | 5.86B |
Indicative Equilibrium Price | 226 | 585 |
Indicative Equilibrium Volume | 1K | 2.54K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Super Bank Indonesia Tbk. (hereinafter referred to as the Bank) formerly under the name of PT Bank Fama International was established by Deed No. 36 on 5 March 1993, before Notary Herlien, S.H. The Bank has received a license as a commercial bank according to the Decree of the Minister of Finance of the Republic of Indonesia No. 834/KMK.017/1993 dated 11 October 1993.
Read more on SUPA →